Diabetes Flashcards

1
Q

Pathophysiology of T1DM

A

Type 1 diabetes is caused by the autoimmune destruction of the insulin- producing b-cells of the islets of Langerhans. Genetic and environmental factors are thought to play a part in the onset of the disease, which usually occurs in childhood and young adulthood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pathophysiology of T2DM

A

type 2 diabetes mellitus is characterized by peripheral insulin resistance, impaired regulation of hepatic glucose production, and declining β-cell function, eventually leading toβ -cell failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Clinical presentation of T1DM

A
  • Feeling more thirsty than usual
  • Urinating a lot
  • Losing weight without trying
  • Blurry vision
  • Ketosis
  • Polyuria
  • Polydipsia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical presentation of T2DM

A
  • Feeling more thirsty than usual
  • Urinating a lot
  • Losing weight without trying
  • Fatigue
  • Slow healing of wounds
  • Frequent infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Tests used for diagnosis of diabetes

A

BGLs
Oral glucose tolerance test (OGTT)
Glycosylated haemoglobin (HbA1c)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Long term complications of diabetes

A
  • Glaucoma
  • Cataracts
  • gastroparesis
  • Peripheral neuropathy
  • Coronary artery disease
  • Sexual dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Risk factors for T2DM

A
  • Have prediabetes.
  • Are overweight.
  • Are 45 years or older.
  • Have a parent, brother, or sister with type 2 diabetes.
  • Are physically active less than 3 times a week.
  • Have ever had gestational diabetes (diabetes during pregnancy) or given birth to a baby who weighed over 9 pounds.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rationale for drug use Diabetes

A

Symptom relief (eg polyuria, polydipsia).

Control of blood glucose concentration.

Prevention or delay of long-term microvascular complications (eg nephropathy, neuropathy, retinopathy) and macrovascular events.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Management of T1DM

A

Basal bolus
Split mix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pros and cons of basal bolus VS split mix

A

Split-Mixed Regime: 2 daily injections of a premixed insulin eg NovoMix 30 (30% short acting, 70% intermediate acting). Simple, convenient, lower risk of hypos, less flexible, can’t skip meals.
Basal-bolus Regime: 3 short acting (before meals), 1 long acting (eg Lantus) injections daily. Flexible, better BSL control, regular BSL monitoring needed, doesn’t cover snacks, risk of hypos.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Short acting VS long acting insulin

A

Short/rapid Acting: better control, more flexible but also more injections & more risk of hypos.
Long acting: fewer injections, less risk of hypos but also less flexible & looser control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Goals of T2DM management

A
  • Relieve symptoms of hyperglycaemia (eg polyuria, polydipsia, as well as more subtle changes related to general wellbeing)
  • Avoid acute complications of hyperglycaemia, such as diabetic ketoacidosis
  • Avoid hypoglycaemia
  • Reduce chronic complications.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Management strategies for T2DM

A
  • Individualised treatment targets
  • A healthy eating plan
  • An exercise plan
  • Ways to reduce cardiovascular risk, in particular smoking cessation, blood pressure control and dyslipidaemia management
  • SNAP: quit Smoking, improve Nutrition (lose weight if needed), moderate Alcohol, increase Physical activity.
  • Using noninsulin anti-hyperglycaemic drugs, if required
  • Using insulin, if required
  • Education in self-monitoring, adjusting treatment and how to cope with illness that affects the patient’s blood glucose concentration
  • Screening for, and treating, complications of diabetes (see Diabetes: complications)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Steps for T2DM if exercise and diet alone don’t work

A
  1. Add Metformin
  2. Add an additional drug: either DPP-4 inhibitor or GLP-1 agonist
  3. Add a sulfonylurea. If this fails add a DPP-4 inhibitor OR GLP-1 agonist OR acarbose OR thiazolidinediones
  4. Add insulin

Alt: continue metformin and add a basal bolus

T2DM medication management
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drugs for Diabetes management

A

Both T1DM and T2DM
Insulin
Biguanides
T2DM only
Alpha-glucosidase inhibitors
Meglitinides
SGLT2 Inhibitors
DPP-4 Inhibitors
GLP-1 Agonists
Sulfonylureas
Thiazolidinediones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indication
GLP-1 agonists

A

T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MOA
GLP-1 agonists

A

Incretin therapies are utilised to help balance insulin levels in hormones in the GI tract.
Stimulating glucose-dependent insulin release from the pancreatic islets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Adverse effects
GLP-1 agonists

A
  • Nausea
  • Injection site reactions
  • Headache
  • Nasopharyngitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Drug interactions
GLP-1 agonists

A

Other drugs that could lead to hypoglycaemia:
* insulins
* Sulfonylureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Advantages
GLP-1 agonists

A
  • No hypos
  • Reduced CVD
  • Improved NAFLD
  • Once a week therapy possible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Disadvantages
GLP-1 agonists

A
  • Requires injection
  • Pancreatitis
  • Thyroid cancer
  • Gall bladder disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Suffix
GLP-1 agonists

A

“glutide”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Drug class that ends in
“glutide”

A

GLP-1 agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Indication
Sulfonylureas

A

T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

MOA
Sulfonylureas

A

Increase pancreatic insulin secretion; may decrease insulin resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Contraindications
Sulfonylureas

A

Ketoacidosis
T1DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Adverse effects
Sulonylureas

A

Hypoglycaemia
Weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Practice points
Sulfonylureas

A
  • With food to decreased risk of hypoglycaemia
  • Controlled release tablet – DO NOT CRUSH
  • Avoid binge drinking, eat when drinking alcohol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Advantages
Sulfonylureas

A
  • Relatively inexpensive
  • Multiple formulations
  • Minimal side effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Disadvantages
Sulfonylureas

A

Progression of T2DM and increased insulin resistance
(secondary failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Indication
DPP-4 inhibitors

A

T2DM

32
Q

MOA
DPP-4 inhibitors

A

Inhibit DPP‑4 thereby increasing the concentration of the incretin hormones GLP-1; glucose-dependent insulin secretion is increased and glucagon production reduced.
= reduction in BGLs

33
Q

Contraindications
DPP-4 inhibitors

A
  • Type 1 Diabetes
  • Diabetic Ketoacidosis
34
Q

What is Diabetic Ketoacidosis

A

Diabetic ketoacidosis aka DKA involves rapid progression (24hrs) prolonged hyperglycaemia, lathargy, polyuria, polydipsia, and weight progress to neurologic symptoms, including lethargy, focal signs
eventually coma

35
Q

Adverse effects
DPP-4 inhibitors

A
  • Upper respiratory tract infection
  • Nasopharyngitis
  • Urinary tract infection
  • Headache
36
Q

Practice points
DPP-4 inhibitors

A

Can be taken with/without food

37
Q

Advantages
DPP-4 inhibitors

A
  • No hypos
  • Weight neutral
  • Decrease postprandial glucose
38
Q

Disadvantages
DPP-4 inhibitors

A
  • Heart failure
  • Pancreatic disease
  • Arthritis
39
Q

Suffix
DPP-4 inhibitors

A

“gliptin”

40
Q

Drug class ending in
“gliptin”

A

DPP-4 inhibitors

41
Q

Suffix
SGLT2 inhibitors

A

“flozin”

42
Q

Drug class that ends in
“flozin”

A

SGLT2 inhibitors

43
Q

Indication
SGLT2 inhibitors

A

T2DM
Think SGLT2 inhibitors

44
Q

MOA
SGLT2 inhibitors

A

SGLT2 inhibitors function through a novel mechanism of reducing renal tubular glucose reabsorption, producing a reduction in blood glucose without stimulating insulin release.

45
Q

Contraindications
SGLT2 inhibitors

A

Renal impairment

46
Q

Adverse effects
SGLT2 inhibitors

A
  • Genital infections
  • Flu like symptoms
  • Urge to urinate
47
Q

Drug interactions
SGLT2 inhibitors

A

Diuretics

Both are acting on the kidneys reabsorption or excretion of substances combination may result in increased diuretic effect = hypotension and electrolyte imbalance

48
Q

Practice points
SGLT2 inhibitors

A
  • Patients on SGL2 inhibitors should be educated to check for ketones if they feel unwell even BSL if not elevated
  • Ensure adequate water intake to avoid dehydration
49
Q

Advantages
SGLT2 inhibitors

A
  • No hypos
  • Decrease heart failure
  • Decrease renal function
  • Once a day dose
50
Q

Disadvantages
SGLT2 inhibitors

A
  • Genetic myotic infections
  • Increased LDL
  • Increased risk of DKA
  • Postural hypotension
51
Q

Metformin aka…

A

Biguanide

52
Q

Indication
Metformin

A

T2DM

53
Q

MOA
Metformin

A

Reduces hepatic glucose production; increases peripheral utilisation of glucose

54
Q

Contraindications
Metformin

A
  • Patients with metabolic acidosis
  • Renal dysfunction (eGFR <30mL/min)
  • Impaired hepatic function
55
Q

Adverse reactions
Metformin

A
  • Gastrointestinal distress
  • Vomiting
  • Nausea
  • Cramps
  • Diarrhoea
  • Anorexia
56
Q

Practice points
Metformin

A
  • Take with/after food to decrease stomach upset
  • Controlled release table – DO NOT CRUSH
  • Monitor renal function – every 4-6 months
  • Watch for lactic acidosis
57
Q

Advantages
Metformin

A
  • Lower blood glucose levels
  • Make patient feel better
  • Improve long term health
  • Inexpensive
  • No hypos
  • Once daily
58
Q

Disadvantages
Metformin

A
  • GI side effects
  • B12 deficiency
  • Need to monitor renal function
59
Q

Indication
Insulin

A

Type 1 diabetes
Type 2 diabetes where: Inadqautely controlled with diet, exercise, and oral anti-diabetic drugs

60
Q

MOA
Insulin

A

Insulin promotes glucose and amino acid uptake into muscle and adipose tissues, and other tissues except brain and liver. It also has an anabolic role in stimulating glycogen, fatty acid, and protein synthesis. Insulin inhibits gluconeogenesis in the liver. Insulin binds to the insulin receptor (IR), a heterotetrameric protein consisting of two extracellular alpha units and two transmembrane beta units. The binding of insulin to the alpha subunit of IR stimulates the tyrosine kinase activity intrinsic to the beta subunit of the receptor.

61
Q

Contraindications
Insulin

A
  • Diarrhoea
  • Fever
  • Hepatic disease
  • Hypoglycaemia
62
Q

Adverse effects
Insulin

A
  • Weight gain
  • Lipohypertrophy
  • Hypoglycaemia
63
Q

Drug interactions
Insulin

A
  • Oral contraceptives
  • Antibiotics
  • Nicotinic acids
64
Q

Advantages
Insulin

A
  • Lower blood glucose levels
  • Make patient feel better
  • Improve long term health
65
Q

Disadvantages
Insulin

A
  • Can lead to hypos
  • Weight gain
66
Q

Clinical signs of Hypoglycaemia

A
67
Q

Signs and symptoms
Hypoglycaemia

A
  • cool & clammy skin
  • Sweating (diaphoresis)
  • palpitations
  • Fatigue and weakness
  • Confusion
  • Headache
  • Shakiness
  • unrousable
  • Coma
68
Q

Treatment
Hypoglycaemia

A

Conscious
* 15g carbs: juice, soda
* recheck BGL 15 mins later
* Give another 15g carbs

Unconscious
Administer IV 50% glucose injection

69
Q

Signs and symptoms
Hyperglycaemia

A
  • polyuria (peeing alot)
  • Polydipsia (thirst)
  • Polyphagia (hunger)
  • Hot and dry skin
  • Dry mouth
  • Fruity breath
  • Deep rapid breaths
  • Numbness and tingling
  • slow wound healing
  • Vision changes
70
Q

Treatment
Hyperglycaemia

A

Administer insulin
Test for ketones

71
Q

Types of insulins

A

Rapid acting insulin
Short acting
Intermediate acting
Long acting
Mixed

72
Q

Brain dump
Rapid acting insulin

A

onset: 5–15 minutes
peak: 0.5–1.5 hours
duration: 3–5 hours

give at start of meal

compared to standard insulin aspart:
marginally faster time to effect
may increase infusion site reactions and need for non-routine change of infusion pump
**Increased risk of hypos **

Drug names: Aspart (NovoRapid), lispro, glulisine

73
Q

Brain dump
Short acting insulin

A

onset: 30 minutes
peak: 2–3 hours
duration: 6–8 hours

give within 30 minutes before meal
soluble insulin
clear solution

Drug names human / neutral insulin (Actrapid)

74
Q

Brain dump
Intermediate insulin

A

onset: 1–2.5 hours
peak: 4–12 hours

duration: 16–24 hours

also known as intermediate-acting insulins
give once or twice daily
cloudy solution

Drug names Isophane insulin (Humilin NPH)

75
Q

Brain dump
Long acting insulin

A

insulin detemir (Levemir)
onset: 1–2 hours
peak: 6–8 hours
duration: 12–24 hours
give once or, more commonly, twice daily (effect often wears off before 24 hours)
clear solution
do not mix with other insulins; inject separately

Insulin glargine 100 units/mL (Optisulin)
onset: 1–2 hours
no peak
duration: 24 hours
give once daily
provides a constant basal insulin level
do not mix with other insulins; inject separately
clear solution
the 2 strengths are not directly interchangeable

76
Q

Brain dump
Mixed insulin

A

insulin aspart with aspart protamine (NovoMix 30)

onset: 10–15 minutes
peak: 1 hour
duration: 16–18 hours
also known as biphasic insulins
give once or twice daily
give immediately before meal(s)
cloudy solution

77
Q

Indication
Glucagon

A

Hypoglycaemia
Taken orally